These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19307678)

  • 21. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.
    Kudo M
    Oncology; 2008; 75 Suppl 1():1-12. PubMed ID: 19092266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic therapy for hepatocellular carcinoma.
    Thomas MB
    Cancer J; 2008; 14(2):123-7. PubMed ID: 18391618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment options for hepatocellular carcinoma.
    Sandhu DS; Tharayil VS; Lai JP; Roberts LR
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatocellular carcinoma].
    Kondo S; Ueno H; Morizane C; Okusaka T
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1219-23. PubMed ID: 20647702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic therapies in hepatocellular carcinoma.
    Wörns MA; Weinmann A; Schuchmann M; Galle PR
    Dig Dis; 2009; 27(2):175-88. PubMed ID: 19546557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet count less than SHARP: what does a case series reveal?
    Saif MW
    Expert Opin Drug Saf; 2010 Jan; 9(1):1-8. PubMed ID: 20001607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma.
    Zhu AX
    Expert Opin Investig Drugs; 2010 May; 19(5):663-72. PubMed ID: 20367287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the treatment response of HCC.
    Kim KW; Lee JM; Choi BI
    Abdom Imaging; 2011 Jun; 36(3):300-14. PubMed ID: 21279353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of hepatocellular carcinoma.
    Lau WY
    J R Coll Surg Edinb; 2002 Feb; 47(1):389-99. PubMed ID: 11874260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of hepatocellular carcinoma.
    Said A; Wells J
    Minerva Med; 2009 Feb; 100(1):51-68. PubMed ID: 19277004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular pathogenesis and targeted therapy of hepatocellular carcinoma.
    Zender L; Kubicka S
    Onkologie; 2008 Oct; 31(10):550-5. PubMed ID: 18854656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opportunities for targeted therapies in hepatocellular carcinoma.
    Thomas MB; Abbruzzese JL
    J Clin Oncol; 2005 Nov; 23(31):8093-108. PubMed ID: 16258107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety.
    Vitale A; Volk ML; Pastorelli D; Lonardi S; Farinati F; Burra P; Angeli P; Cillo U
    Hepatology; 2010 Jan; 51(1):165-73. PubMed ID: 19877181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical therapies to extend survival in hepatocellular carcinoma.
    Gish R; Marrero JB; Tong MJ
    Clin Adv Hematol Oncol; 2008 Aug; 6(8):1-14; quiz 15. PubMed ID: 18833600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma: current management and recent advances.
    Lau WY; Lai EC
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):237-57. PubMed ID: 18522878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancer.
    Blumenschein GR; Gatzemeier U; Fossella F; Stewart DJ; Cupit L; Cihon F; O'Leary J; Reck M
    J Clin Oncol; 2009 Sep; 27(26):4274-80. PubMed ID: 19652055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
    Hussain K; El-Serag HB
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):123-38. PubMed ID: 19305372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sorafenib in hepatocellular carcinoma: separating the hype from the hope.
    Kelley RK; Venook AP
    J Clin Oncol; 2008 Dec; 26(36):5845-8. PubMed ID: 19029408
    [No Abstract]   [Full Text] [Related]  

  • 39. Markedly effective local control of hepatocellular carcinoma with a poor prognosis by combined multimodal therapy with sorafenib as a neoadjuvant approach.
    Bathaix F; Marion D; Cuinet M; Maillard E; Zoulim F; Mornex F; Merle P
    Gastroenterol Clin Biol; 2010; 34(4-5):314-8. PubMed ID: 20207091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The treatment of hepatocellular carcinoma: an update].
    Vero V; Racco S; Biolato M; Pompili M; Gasbarrini G; Miele L; Grieco A
    Minerva Med; 2009 Jun; 100(3):173-93. PubMed ID: 19571783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.